✦ LIBER ✦

Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation

✍ Scribed by Olaf Anselm Brinkmann; Frank Bruns; Georg Gosheger; Oliver Micke; Lothar Hertle

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 374 KB
Volume: 23
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-004-0479-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of locally advanced squamous c

Treatment of locally advanced squamous cell carcinoma of the head and neck with concurrent bleomycin and external beam radiation therapy

✍ Stephen L Seagren; John E Byfield; Alan M Nahum; Robert C Bone 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 437 KB

The fate and prognostic value of occult

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

✍ Wolfgang Janni; Florian Hepp; Dorothea Rjosk; Christina Kentenich; Barbara Strob 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Local recurrence after vertical partial

Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I–II squamous cell carcinoma of the glottis

✍ Ollivier Laccourreye; Raimundo Gutierrez-Fonseca; Dominique Garcia; Stéphane Han 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## BACKGROUND. Based on an inception cohort of 103 patients who had local recurrence (Group I) and a witness group of 311 patients who achieved local control (Group II) after vertical partial laryngectomy for Stage I-II glottic carcinoma, the current retrospective study documented the consequences

Local recurrence, rate and sites of meta

Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones

✍ Richard Evans; Mark Nesbit; Fred Askin; Omer Burgert; Ayten Cangir; Mary Foulkes 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Subcutaneous interleukin-2 and interfero

Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin-2 and interferon α : Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie

✍ Alain Ravaud; Rémy Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The main objective of this trial was to evaluate the combination of subcutaneous (sc) interleukin-2 (il-2) with interferon alpha-2a (ifn-alpha) in the treatment of patients with metastatic renal cell carcinoma (mrcc) compared with a previous trial that used continuous-infusion il-2 a